Skin Self-Examination Education During Mammography

NCT03512457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2021-04-13

Study results available
· View outcomes & findings →

Summary

The skin self-examination for melanoma (SSE) educational materials were developed with the input provided by women undergoing screening mammograms. The investigators seek to evaluate the performance of SSE by women and find out if women seek care with a dermatologist for a concerning mole or for a melanoma screening examination by a dermatologist after reviewing the materials received during the mammogram visit. The purpose of this study is to enhance the early detection of melanoma among women who are engaging in health promotion by having mammograms. The investigators specifically aim to evaluate the performance of SSE by women, who receive information during their mammogram appointment, and then follow-up with dermatology for a melanoma screening examination.

Conditions

Interventions

BEHAVIORAL

Minimal Intervention

Women view an educational poster in changing room, and they receive a brochure.

BEHAVIORAL

Intensive Intervention

Women view an educational poster in changing room, and they receive a brochure.

Sponsors & Collaborators

  • Sarah M. Friedewald, MD

    collaborator UNKNOWN
  • Jennifer N. Choi, MD

    collaborator UNKNOWN
  • Northwestern University

    lead OTHER

Principal Investigators

  • June K. Robinson, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-30
Primary Completion
2018-10-24
Completion
2018-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03512457 on ClinicalTrials.gov